For nearly four decades, cancer researchers faced a persistent problem. They knew that a mutation in a gene called KRAS was driving some of the deadliest tumors for pancreatic, lung, and colorectal cancers, but every attempt to build a drug that could block it came up short.
Similar Posts
Transforming Your Dental Health: A Step-by-Step Approach
If you want to get that smile you’ve dreamt about, a visit to a dentist may…
DIY Wax Melts With Essential Oils
Ahhh, the joys of taking a moment to relax and breathe in that new scented wax…
ISPOR’s 2024 HEOR Awards – Healthcare Economist
Who won the ISPOR’s 2024 HEOR awards? The list is below. Avedis Donabedian Lifetime Achievement Award:…
Do wait times for breast cancer surgery in the UK vary by socioeconomic status? – Healthcare Economist
One of the key benefits of the UK health system is that everyone has access to…
Fitness Pros Love Steady-State Cardio. Here’s Why You Should Give It a Try
All cardio training tends to get lumped together in one big bucket. There’s the misconception that…
What’s behind all these assessments of digital health? – The Health Care Blog
By MATTHEW HOLT A decent amount of time in recent weeks has been spent hashing out…
